Shares of C3.ai Inc. AI slipped 1.98% to $23.25 Friday, on what proved to be an all-around mixed trading session for the ...

After listening to the enterprise AI specialist's latest earnings call, I have some concerns over where the company is headed ...

C3.ai is implementing a successful strategy to increase customer counts. Fool.com contributor and finance professor Parkev ...

Shares of C3.ai Inc. AI sank 0.26% to $23.27 Wednesday, on what proved to be an all-around grim trading session for the stock ...

Investors should always rely on their own analysis, not just management talk and projections, when deciding whether to buy a ...

C3.ai's growth is fairly modest given its size and the strength of the demand environment. Read why I remain neutral on AI ...

We recently published a list of 10 AI News and Analyst Ratings You Should Not Miss. Since C3.ai Inc (NYSE:AI) ranks 10th on ...

Cannabinoid-focused biopharmaceutical company C3 Pharmaceuticals announces a planned listing on the Canadian Securities ...

The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

Enterprises and institutions are rushing to develop an AI strategy, which will be a tailwind for these two AI stocks.

Executives are fighting back against a federal court decision that banned them from the securities industry and ordered them ...

Here's everything you need to know about the concepts and production models that will be showcased in Paris this October ...